Peptide Medication Breakthrough

News   Feb 22, 2018 | Original story from Technical University of Munich

 
Peptide Medication Breakthrough

Cyclic hexapeptide in its bioactive form with the integrin-binding tripeptide sequence arginine-glycine-aspartic acid: Green spheres represent carbon atoms, red oxygen atoms, blue nitrogen atoms and white hydrogen atoms. Yellow spheres represent the two N-methyl groups and dashed orange lines show the two intramolecular hydrogen bonds. Arrangement (clockwise): arginine (top), glycine, aspartic acid, alanine, N-methylated alanine, N-methylated D-valine. Credit: Michael Weinmueller / TUM

 
 
 

RELATED ARTICLES

Research Team Discovers Compound that Stops Cancer From Spreading

News

Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.

READ MORE

PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

News

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.

READ MORE

Simple Sugar Prevents Neurodegeneration in Lysosomal Storage Disease

News

New therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB)

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy